WebCullinan Oncology is dedicated to creating new standards of care for patients with cancer. We innovate without borders to find the most promising clinic-ready cancer therapies, … WebApr 12, 2024 · 3 Wall Street analysts have issued 12 month target prices for Cullinan Oncology's stock. Their CGEM share price forecasts range from $19.00 to $50.00. On average, they predict the company's stock price to reach $34.50 in the next year. This suggests a possible upside of 217.1% from the stock's current price. View analysts price …
8-K: Cullinan Oncology, Inc. - MarketWatch
WebWith patient benefit as our priority, we leverage our scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and select the optimal … Cullinan Oncology has built a diversified pipeline by identifying high-impact … Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug … At Cullinan Oncology, our research is anchored in a deep understanding of … Zipalertinib (CLN-081/TAS6417) A Phase 1/2a, Open-label, multicenter, first-in … Taking a modality-agnostic approach offers incredible freedom to develop the most … www.cullinanoncology.com bkwoods32 gmail.com
Investor Relations Cullinan Oncology, Inc
WebJun 4, 2024 · Jun 04 2024. CAMBRIDGE, Mass.– ( BUSINESS WIRE )–Cullinan Oncology, LLC announced today the closing of a $98.5 million Series B financing, which will be used to support ongoing clinical trials across its small molecule and biologics portfolio. New institutional investors and family offices participated in the financing alongside … WebDec 28, 2024 · Dec 28, 2024 7:58AM EST. (RTTNews) - Zai Lab Limited (ZLAB) said that it has reached a license agreement with Cullinan Oncology to develop, manufacture and commercialize CLN-081 in China. CLN-081 ... WebFeb 24, 2024 · Cullinan Oncology has 1 employees at their 1 location and $18.94 m in annual revenue in FY 2024. See insights on Cullinan Oncology including office … bkworld rupaul